Pfizer Inc. said its earnings rose 14%...

Pfizer Inc. said its earnings rose 14% to $219.8 million for its first quarter, compared to $192 million for the year-ago period. The New York pharmaceutical company attributed the gain to strong sales in all five of its business segments, including health-care products and specialty chemicals. Worldwide pharmaceutical sales increased 16%, led by a 33% increase in sales of Feldene, Pfizer’s anti-arthritic medicine, with gains in all of its other major areas of therapeutic drugs, the company said.